Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases
Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases: A Prospective Case-Control Study
Assiut University
700 participants
May 30, 2025
OBSERVATIONAL
Conditions
Summary
This upcoming case-control study aims to confirm the Lung Sliding Index (LSI), a new ultrasound score that measures how well the pleura moves, in various lung diseases. The study will check how well the LSI can tell apart different lung diseases (like pneumothorax, interstitial lung disease, COPD, pneumonia, and pulmonary edema), how it relates to signs of disease severity, and how consistent the results are between different operators who have received the same training. Secondary objectives include assessing patient and operator satisfaction and feasibility using validated Likert scales.
Eligibility
Inclusion Criteria3
- Age 18 years and older.
- Diagnosed with one of the specified pulmonary diseases, or a healthy control
- Able to provide written informed consent
Exclusion Criteria5
- Inability to tolerate or undergo a lung ultrasound
- Extensive chest wall pathology precluding assessment
- Unscorable \>2 zones per protocol
- Withdrawal of consent
- Mechanically-ventilated patients
Interventions
All enrolled patient will be subjected to Lung Ultrasound examination LUS
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06983366